Genentech
South San Francisco · 21 people tracked
Investment thesis
Genentech focuses on advancing groundbreaking research in neuroscience to address hundreds of neurological disorders affecting nearly 100 million Americans. The firm prioritizes development of medicines for both common and rare neurological conditions, combines scientific innovation with equitable healthcare access initiatives, engages underrepresented communities in research recruitment, and partners with stakeholders to ensure broader access to care as global aging increases neurological disorder prevalence.
Source: firm website, verified Aug 6, 2026.
Team · 21 people
from the firm's website
Frequently asked questions
- What sectors does Genentech focus on?
- Genentech focuses on Biotech.
- Where is Genentech located?
- Genentech is headquartered in South San Francisco, US.
Images
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.